MODITOPE
Live / Registered — Registered (as of 14 Jan 2025)
What this means for you
Registered since 14 Jan 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98107336
- Registration number
- 7647902
- Mark type
- Stylized text
- Filed
- 28 Jul 2023
- Published for opposition
- 26 Nov 2024
- Registered
- 14 Jan 2025
- Attorney of record
- Andrew D. Price
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, for the treatment of cancer; therapeutic preparations and substances, namely, for the treatment of cancer; chemical preparations, namely, for the treatment of cancer; diagnostic reagents for medical use; DNA, antibodies and proteins that stimulate high-avidity T-cells responses for therapeutic and medical use, namely, for the treatment of cancer; pharmaceutical compounds for treatment of cancer; vaccine preparations and substances; peptide vaccines; DNA vaccines and substances
Owner
- Scancell Limited, Oxford, GB
- Scancell Limited, Oxford, GB
- Scancell Limited, Oxford, GB
Prosecution history
- 14 Jan 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 14 Jan 2025 — REGISTERED-PRINCIPAL REGISTER
- 26 Nov 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 26 Nov 2024 — PUBLISHED FOR OPPOSITION
- 20 Nov 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 02 Nov 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 09 Oct 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 09 Oct 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 09 Oct 2024 — ASSIGNED TO LIE
- 24 Jun 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 17 Apr 2024 — NOTIFICATION OF PRIORITY ACTION E-MAILED
- 17 Apr 2024 — PRIORITY ACTION E-MAILED
- 17 Apr 2024 — PRIORITY ACTION WRITTEN
- 29 Mar 2024 — ASSIGNED TO EXAMINER
- 28 Aug 2023 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED